0001415889-24-005476.txt : 20240227 0001415889-24-005476.hdr.sgml : 20240227 20240227161731 ACCESSION NUMBER: 0001415889-24-005476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PICKERING GRANT CENTRAL INDEX KEY: 0001258693 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 24686996 MAIL ADDRESS: STREET 1: C/O VAXCYTE, INC. STREET 2: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 form4-02272024_090231.xml X0508 4 2024-02-23 0001649094 Vaxcyte, Inc. PCVX 0001258693 PICKERING GRANT C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 true true false false CHIEF EXECUTIVE OFFICER 1 Common Stock 2024-02-23 4 M 0 15000 1.79 A 390814 D Common Stock 2024-02-23 4 S 0 2356 75.154 D 388458 D Common Stock 2024-02-23 4 S 0 6980 75.962 D 381478 D Common Stock 2024-02-23 4 S 0 5545 76.952 D 375933 D Common Stock 2024-02-23 4 S 0 119 77.56 D 375814 D Common Stock 2024-02-26 4 M 0 30000 1.79 A 405814 D Common Stock 2024-02-26 4 S 0 30000 79.030 D 375814 D Common Stock 149978 I By Children's Trust Common Stock 149978 I By Children's Trust Stock Option (Right to Buy) 1.79 2024-02-23 4 M 0 15000 0 D 2027-05-17 Common Stock 15000 60225 D Stock Option (Right to Buy) 1.79 2024-02-26 4 M 0 30000 0 D 2027-05-17 Common Stock 30000 30225 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023. The price reported is a weighted-average price. The shares were sold at prices ranging from $74.45 to $75.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $75.545 to $76.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $76.54 to $77.475. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $79.03 to $79.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Shares are held directly by a trust for the benefit of the Reporting Person's son. Stock Option is fully vested and exercisable. /s/ Ron A. Metzger, Attorney-in-Fact 2024-02-27